Brief: F D C Says Manufacturing Unit At Roha Completes US FDA Inspection With No Observations
27/03/2023 08:11
March 27 (Reuters) - F D C Ltd FDC.NS :
* MANUFACTURING UNIT LOCATED AT ROHA THAT MANUFACTURES
ACTIVE
PHARMACEUTICAL INGREDIENT PRODUCTS INSPECTED BY US FDA FROM
MARCH 20-24
* AUDIT HAS BEEN SUCCESSFULLY COMPLETED BY US FDA WITH 'NO
OBSERVATIONS
Source text for Eikon: ID:nBSE5mNz2C
Further company coverage: FDC.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on FDC
See all newsBrief: FDC To Consider Proposal For Buyback Of Equity Shares Via Tender Offer
Brief: F D C Says High Court Granted Interim Stay To Impugned Notice Of FSSAI
Brief: F D C June-Quarter Consol Profit 1.32 Billion Rupees
India's FDC drops after Maharashtra FDA seizes certain 'Enerzal' stock
Brief: F D C Says Food Safety Officials Visited Company's Warehouse At Chhatrapati Sambhaji Nagar And Nagpur